The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin

Cancer Treatment Reviews

Volumn 17, Issue 4, 1990, Pages 389-407

  Meijer, C ^a   Mulder, N H ^a   de Vries, E G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CATALASE; CHLORAMBUCIL; CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETACRYNIC ACID; FREE RADICAL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; HYDROGEN PEROXIDE; HYDROXYL RADICAL; METALLOTHIONEIN; OXYGEN; PIRIPROST; SELENIUM;

ANTIOXIDANT ACTIVITY; BIOSYNTHESIS; CANCER CHEMOTHERAPY; CELL MEMBRANE TRANSPORT; DNA REPAIR; DNA SYNTHESIS INHIBITION; DRUG CONCENTRATION; DRUG CYTOTOXICITY; DRUG DETOXIFICATION; DRUG DNA BINDING; DRUG INACTIVATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESISTANCE; ENZYME INHIBITION; ENZYME SPECIFICITY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MODULATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATION REDUCTION REACTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR CLASSIFICATION;

CISPLATIN; DNA REPAIR; DOXORUBICIN; DRUG RESISTANCE; GLUTATHIONE; HUMAN; MEMBRANE GLYCOPROTEINS; METABOLIC DETOXICATION, DRUG; METALLOTHIONEIN; NEOPLASMS; P-GLYCOPROTEIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0025569131     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-7372(90)90081-P     Document Type: Article

References (120)

1. Phase I trial of menadiol sodium diphosphate (Synkavite®) (M) in advanced cancer
2. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells
3. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells
4. Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells
5. Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion
6. Cis-diammine-dichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
7. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells
8. Glutathione metabolism as a determinant of therapeutic efficacy: a review
9. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals
10. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein
11. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
12. Characterization of a cis-diamminedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
13. Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells
14. 1 and GST π genes and tumor response in 35 advanced neuroblastomas
15. Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumor samples from human lung
16. Comparison of DNA replication and repair enzymology using permeabilized baby hamster kidney cells
17. The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells
18. Inhibition of glutathione S-transferases from rat liver by S-nitroso-Lglutathione
19. Heterogeneous intratumor glutathione levels measured in human lung tumor and normal lung biopsies
20. Multifactorial resistance to adriamycin: Relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia
21. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines
22. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
23. Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells
24. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up
25. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones
26. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents
27. Resistance to anticancer quinone induced cytotoxicity produced by introduction of glutathione-S-transferase (GST) into human MCF-7 breast cancer cells
28. Doxorubicin (D) resistance conferred by selective enhancement of intracellular glutathione peroxidase (GSH-Px) or superoxide dismutase (SOD) content in human MCF-7 breast cancer cells
29. Mechanism of action of glutathione dependent enzymes
30. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells
31. Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes
32. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
33. Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine
34. Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in BE human colon carcinoma cells
35. Determinant of drug exposure in a cisplatin resistant human lung cancer cell line
36. Glutathione S-transferase (GST) isoenzyme expression in normal and malignant human ovarian biopsies
37. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-Butyl Homocysteine Sulfoximine)
38. Phase I trial of buthionine sulfoximine (BSO) plus melphalan (L-PAM) in patients with advanced cancer
39. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
40. Role ofglutathione (GSH) and glutathione S-transferase (GST) in resistance of colon cancer cell lines to melphalan (M), BCNU and cisplatin (CP)
41. Glutathione-dependent synthesis of deoxyribonucleotides
42. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells
43. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance
44. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro
45. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (hSCLC) cell line
46. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells
47. Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia
48. Biochemistry of metallothionein
49. 1 and GST-π in human breast tumours: comparison to in vitro chemosensitivity
50. Effect of endogenous glutathione, superoxide dismutases, catalase, and glutathione peroxidase on adriamycin tolerance of chinese hamster ovary cells
51. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells
52. Overexpression of metallothioncin confers resistance to anticancer drugs
53. The glutathione status of cells
54. Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro
55. Role of the glutathione redox cycle in acquired and de novo multidrug resistance
56. Glutathione-S-transferase activity in human superficial transitional cell carcinoma of the bladder (comparison with healthy controls)
57. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines
58. Depletion of tumor versus normal tissue glutathione by buthionine sulfoximine
59. Isolation by flow cytometry of a human ovarian tumor cell subpopulation exhibiting a high glutathione content phenotype and increased resistance to adriamycin
60. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer—a possible indicator of chemosensitivity
61. Heterogeneity of glutathione content in human ovarian cancer
62. Glutathione as a determinant of cellular response to doxorubicin
63. Molecular mechanisms of action of anticancer agents involving free radicals intermediates
64. Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase
65. Glutathione transferases—structure and catalytic activity
66. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia
67. Modulation of alkylator resistance (R) by 2-methyl- 1,4-napthtoquinone (menadione): Phase I trials of combination menadione plus cyclophosphamide (CTX) or mitomycine C (MitC)
68. Observations on the transcriptional activity of the glutathione S-transferase π gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy
69. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line
70. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line
71. Methods for the selective modification of glutathione metabolism and study of glutathione transport
72. Glutathione
73. Quenching of DNA: Platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210
74. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells
75. The relationships between glutathione (GSH), glutathione-S-transferase (GST) and platinum drug cytotoxicity in eight human ovarian carcinoma cell lines (HOC's)
76. Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli: A possible model for mammalian cell protection
77. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors
78. Elevation of π class glutathione S-transferase activity in human breast cancer cells by transfection of the GST π gene and its effect on sensitivity to toxins
79. Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues
80. Glutathione-S-transferase π as a determinant of drug resistance in transfectant cell lines
81. Tumor cell antioxidant defenses
82. Glutathione-S-transferase (GST) activity and glutathione (GSH) concentration in human brain tumor biopsies
83. Glutathione-S-transferase (GST), Pglycoprotein and drug resistance in small-cell lung cancer (SCLC) cell lines
84. Free radical formation by antitumor quinones
85. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells
86. Regulation of τ-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione
87. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells
88. Ethacrynic acid (EA) inhibition of glutathione transferases (GSTs) as a mechanism for enhanced melphalan toxicity in human melanoma
89. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.
90. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese Hamster Ovary Cells expressing elevated glutathione S-transferase activity
91. The biochemistry of glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and glutathione reductase
92. Free radical detoxifying enzymes in adriamycin-resistant cell lines
93. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs
94. Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation
95. Increased expression of glutathione S-transferase gene in cis-Diaminedichloroplatinum(II)-resistant variants of a chinese hamster ovary cell line
96. Expression of the multidrug resistance gene in myeloid leukemias
97. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer
98. Phase I trial of thiotepa (TT) in combination with the glutathione transferase (GST) inhibitor ethacrynic acid (EA)
99. Expression of glutathione S-transferases in primary and metastatic ovarian carcinoma
100. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients
101. Mechanisms of resistance to cis-diamminedichloroplatinum(II) in a rat ovarian carcinoma cell line
102. Glutathione S-transferase isoenzymes in human lung tumors
103. Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells
104. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action
105. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance
106. Enzymatic activation and binding of adriamycin to nuclear DNA
107. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)
108. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell line
109. Modulation of the hydrolysis, transfer, and glutaminase activities of τ-glutamyl transpeptidase by maleate bound at the cysteinylglycine binding site of the enzyme
110. Cisplatin (CP) resistance (res) in the human embryonal carcinoma (ec) cell line NTera2D1 (Tera)
111. Overexpression and amplification of five genes in multidrug-resistant Chinese hamster ovary cell line
112. Active site-directed irreversible inhibition of glutathione S-transferases by the glutathione conjugate of tetrachloro-1,4-benzoquinone
113. Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards
114. Cross-resistance and glutathione-S-transferase π levels among four human melanoma cell lines selected for alkylating agents resistance
115. Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells
116. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin
117. Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stress
118. Comparison of glutathione S-transferase activity between drug-resistant and -sensitive human tumor cells: Is glutathione S-transferase associated with multidrug resistance?
119. Multifactorial drug resistance in an adriamycinresistant human small cell lung carcinoma cell line